牟伊, 宋雨, 文帅, 王燕, 姜正羽. Nrf2抑制剂在肿瘤治疗中的研究进展J. 药学学报, 2022,57(2): 321-330. doi: 10.16438/j.0513-4870.2021-1346
引用本文: 牟伊, 宋雨, 文帅, 王燕, 姜正羽. Nrf2抑制剂在肿瘤治疗中的研究进展J. 药学学报, 2022,57(2): 321-330. doi: 10.16438/j.0513-4870.2021-1346
MOU Yi, SONG Yu, WEN Shuai, WANG Yan, JIANG Zheng-yu. Research progress of Nrf2 inhibitor in tumor therapyJ. Acta Pharmaceutica Sinica, 2022,57(2): 321-330. doi: 10.16438/j.0513-4870.2021-1346
Citation: MOU Yi, SONG Yu, WEN Shuai, WANG Yan, JIANG Zheng-yu. Research progress of Nrf2 inhibitor in tumor therapyJ. Acta Pharmaceutica Sinica, 2022,57(2): 321-330. doi: 10.16438/j.0513-4870.2021-1346

Nrf2抑制剂在肿瘤治疗中的研究进展

Research progress of Nrf2 inhibitor in tumor therapy

  • 摘要: 核因子E2相关因子2(Nrf2)是一种多功能的转录因子,在细胞保护机制中起着至关重要的作用。随着Nrf2调控新模式和新功能研究的不断深入,Nrf2在恶性肿瘤中的促癌作用日益凸显。越来越多的证据表明Nrf2参与了肿瘤的发生、发展、转移和预后的整个过程,抑制Nrf2是一种较有前景的肿瘤治疗策略。目前,Nrf2抑制剂的研究尚处在早期阶段。本文简要介绍Nrf2的生物学功能,以及其在肿瘤发生中的双重作用,并根据结构类型对代表性的Nrf2抑制剂进行综述,为围绕Nrf2调控开发抗肿瘤药物提供借鉴及思路。

     

    Abstract: Nrf2 is a multi-effect transcription factor, which plays a crucial role in cytoprotective system. With the deepening of research on new regulatory modes and biologic functions of Nrf2, the oncogenic role of Nrf2 in malignant transformed tumors is increasingly obvious. More and more evidences show that Nrf2 is involved in the whole process of tumor occurrence, development, metastasis and prognosis, and inhibiting Nrf2 may be a promising strategy in tumor therapy. However, the development of Nrf2 inhibitors is still in early stage. In this paper, the biological function of Nrf2 and its dual role in tumor are briefly introduced, and representative Nrf2 inhibitors are reviewed according to their structure types, so as to provide reference and ideas for the development of anti-tumor drugs centering on the regulation of Nrf2.

     

/

返回文章
返回